Julio Croda
juliocroda.bsky.social
Julio Croda
@juliocroda.bsky.social
Médico infectologista CRMMS 5852/RQE3251
Pesquisador da Fundação Oswaldo Cruz
Professor da Universidade Federal do Mato Grosso do Sul
Reposted by Julio Croda
Thanks to all group team working on it, collaborators and the São Paulo State Health Secretary.
September 18, 2025 at 9:12 AM
🚨 Apenas 50% dos casos de tuberculose nas instituições penais são diagnosticados. Se todos os estados adotassem a triagem em massa com radiografia de tórax — como já fazem MS e MT — poderíamos mudar esse cenário.
🔗 www.campograndenews.com.br/brasil/cidad...
MS lidera ranking de novos casos de tuberculose em presídios
Boletim epidemiológico sobre a tuberculose em pessoas privadas de liberdade, divulgado pelo Ministério da Saúde, mostra que foram registrados 7.718 novos ...
www.campograndenews.com.br
July 27, 2025 at 8:33 PM
Reposted by Julio Croda
We just published a piece about the participation of people deprived of liberty in #tuberculosis vaccine trials. Should they be protected from research, or through research?

www.thelancet.com/journals/lan...

@thelancetinfdis.bsky.social @isglobal.org @mtbi.bsky.social
June 30, 2025 at 11:54 AM
New article just out in The Lancet Infectious Diseases!
"Should people deprived of liberty be protected from research or through research?"

www.sciencedirect.com/science/arti...
The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research?
People deprived of liberty are among the populations experiencing the highest rates of tuberculosis. Prisons typically create ideal conditions for Myc…
www.sciencedirect.com
June 28, 2025 at 12:40 AM
Reposted by Julio Croda
Important new BMJ Global Health paper provides a helpful framework to analyze patient journeys and identify major barriers to accessing healthcare

gh.bmj.com/content/10/5...
May 20, 2025 at 11:23 AM
Thank you to hashtag#WSPIDPodcast for the invitation!
It was a pleasure to discuss the growing burden of dengue and share insights from Brazil.

spoti.fi/42Hi5rR
April 23, 2025 at 2:10 PM
Entrevista a @radiogauchafm a respeito do novo investimento do Ministério da Saúde com objetivo de disponibilizar uma vacina de dengue para as pessoas de 2 a 59 anos em 2026

soundcloud.com/radio-gaucha...
Doutor Julio Croda, médico infectologista - 25/02/2025
Entrevista: Doutor Julio Croda, médico infectologista, pesquisador da Fundação Oswaldo Cruz e professor da Universidade Federal de Mato Grosso do Sul e da Escola de Saúde Pública de Yale, nos EUA P
soundcloud.com
February 26, 2025 at 2:15 AM
Investigamos doses fracionadas vs. completas de reforço para vacinas COVID-19 em um ensaio clínico fase IV no Brasil.
February 22, 2025 at 1:48 PM
Reposted by Julio Croda
February 4, 2025 at 5:33 AM
Entrevista sobre o cenário da dengue no estado do Mato Grosso do Sul na CBN-Campo Grande: www.youtube.com/watch?v=8sR9...
Julio Croda - Infectologista
YouTube video by cbncgoficial
www.youtube.com
February 19, 2025 at 12:38 PM
January 23, 2025 at 12:25 PM
October 23, 2024 at 10:45 PM
Reposted by Julio Croda
We had an incredible meeting in Rio to discuss inclusion of persons deprived of liberty in TB vaccine trials. So many great presentations on ethical and scientific considerations, WHO & MoH policies for vaccine prioritization, community engagement & advocacy. @juliocroda.bsky.social
October 13, 2024 at 5:19 PM
October 22, 2024 at 2:07 PM
🎥 Transmissão ao vivo - REDE-TB: "Engaging Persons Deprived of Liberty in Tuberculosis Vaccine Research Meeting"🌐

📅 Data:07 de outubro de 2024
🕑 Horário:14h (horário de Brasília)

Acesse a transmissão pelo link: www.youtube.com/live/D0txfCI...
YouTube
Share your videos with friends, family, and the world
www.youtube.com
October 7, 2024 at 12:39 PM
Uma honra estar ao lado de dois gigantes da saúde pública e vacinas, Carlos Morel e Akira Homma. Suas contribuições são fundamentais para os avanços que vemos hoje no combate a doenças infecciosas, promovendo uma saúde mais justa e acessível para todos.
October 3, 2024 at 8:18 PM